Tag: resin microspheres
DOORwaY90 clinical trial interim analysis demonstrates efficacy of Y-90 resin microspheres...
An interim analysis of the DOORwaY90 clinical trial has shown that yttrium-90 (Y-90) resin microspheres—SIR-Spheres (Sirtex)—using partition dosimetry, achieved high objective response rates and...
Versatility meets control with SIR-Spheres personalised Y90 radioembolization
This advertorial is sponsored by Sirtex Medical.
When performing liver-directed therapy, precise targeting of tumours is crucial to protect healthy liver tissue. Supporting a tailored...
